NIROGACESTAT HYDROBROMIDE | N217677 | SPRINGWORKS THERAPEUTICS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7795447 | Aug 18, 2030 | — | Yes | — | — | — |
| 10590087 | Aug 9, 2039 | — | Yes | — | — | — |
| 10710966 | Aug 9, 2039 | — | Yes | — | — | |
| 10941118 | Aug 9, 2039 | — | Yes | — | — | |
| 11504354 | Jul 8, 2042 | — | — | Yes | — | — |
| 11612588 | Jul 8, 2042 | — | — | Yes | — | |
| 11807611 | Sep 8, 2042 | — | — | Yes | — | |
| 11820748 | Aug 9, 2039 | — | — | Yes | — | — |
| 11844780 | Sep 8, 2042 | — | — | Yes | — | |
| 11845732 | Aug 9, 2039 | — | Yes | — | — | |
| 11872211 | May 19, 2043 | — | — | — | — | |
| 11884634 | Aug 9, 2039 | — | — | Yes | — | — |
| 11884635 | Aug 9, 2039 | — | — | Yes | — | — |
| 11905255 | Aug 9, 2039 | — | — | Yes | — | — |
| 11925619 | May 19, 2043 | — | — | — | — | |
| 11925620 | May 19, 2043 | — | — | — | — | |
| 11938116 | May 19, 2043 | — | — | — | — | |
| 11951096 | May 19, 2043 | — | — | — | — | |
| 11957662 | May 19, 2043 | — | — | — | — | |
| 12011434 | May 19, 2043 | — | — | — | — | |
| 12011435 | May 19, 2043 | — | — | — | — | |
| 12036207 | May 19, 2043 | — | — | — | — | |
| 12110277 | Jul 8, 2042 | — | — | Yes | — | — |
| 12116347 | Aug 9, 2039 | — | — | Yes | — | — |
| 12138246 | May 19, 2043 | — | — | — | — | |
| 12234210 | Jul 8, 2042 | — | — | Yes | — | — |
| 12247012 | Jul 8, 2042 | — | — | Yes | — | — |
| 12297177 | Aug 9, 2039 | — | — | Yes | — | — |
| 12599587 | Jul 8, 2042 | — | — | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Nov 27, 2028 | Active |
| ODE-452 | Nov 27, 2030 | Active |